HealthEquity, Inc. (HQY) News

HealthEquity, Inc. (HQY): $59.21

0.28 (+0.48%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Filter HQY News Items

HQY News Results

Date Symbol Company Title Start End Change POWR Rating
Loading, please wait...

HQY News Highlights

  • HQY's 30 day story count now stands at 4.
  • Over the past 9 days, the trend for HQY's stories per day has been choppy and unclear. It has oscillated between 1 and 2.
  • The most mentioned tickers in articles about HQY are DECK.

Latest HQY News From Around the Web

Below are the latest news stories about HEALTHEQUITY INC that investors may wish to consider to help them evaluate HQY as an investment opportunity.

Here's Why You Should Retain HealthEquity (HQY) Stock for Now

Investors continue to be optimistic about HealthEquity's (HQY) strength in HSA.

Yahoo | January 18, 2023

HealthEquity (HQY) Presents at the 41st Annual J.P. Morgan Healthcare Conference -- Slideshow

The following slide deck was published by HealthEquity, Inc.

Seeking Alpha | January 12, 2023

HealthEquity projects record HSA sales in FY23

HealthEquity (HQY) said Monday estimated health savings accounts are expected to be ~8M by January 31, up 11.1% Y/Y, reflecting record new openings and custodial asset growth.Estimated…

Seeking Alpha | January 9, 2023

HealthEquity Announces Record HSA Sales Outlook, Presentation at J.P. Morgan Healthcare Conference

DRAPER, Utah, Jan. 09, 2023 (GLOBE NEWSWIRE) -- HealthEquity, Inc. (NASDAQ: HQY) (“HealthEquity” or the “Company”), the nation’s largest health savings account (“HSA") custodian, today announced estimates of HSAs, HSA assets and total accounts for its fiscal year ending January 31, 2023, reflecting record new openings and custodial asset growth. Estimated HSAs are expected to be approximately 8 million by January 31, 2023, up from 7.2 million a year earlier.Estimated HSA assets are expected to b

Yahoo | January 9, 2023

Are Medical Stocks Lagging Gilead Sciences (GILD) This Year?

Here is how Gilead Sciences (GILD) and HealthEquity (HQY) have performed compared to their sector so far this year.

Yahoo | December 21, 2022

HealthEquity Inc. (HQY) will benefit from these strategies

HealthEquity Inc. (NASDAQ:HQY) marked $61.87 per share on Thursday, down from a previous closing price of $63.04. While HealthEquity Inc. has underperformed by -1.86%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, HQY rose by 52.58%, with highs and lows ranging from $79.20 to $38.53, whereas […]

US Post News | December 16, 2022

Stryker's (SYK) Citrefix to Boost Foot and Ankle Surgeries

Stryker's (SYK) newly-launched Citrefix will help customers avoid chronic inflammation using Citregen. Its pull-out strength is greatly increased compared to other suture anchors.

Yahoo | December 16, 2022

Zacks Industry Outlook Highlights Medpace, HealthEquity and Progyny

Medpace, HealthEquity and Progyny have been highlighted in this Industry Outlook article.

Yahoo | December 16, 2022

3 Medical Services Stocks to Buy Amid Industry Challenges

The Zacks Medical - Services industry is growing on digital healthcare adoption. MEDP, HQY and PGNY are set to gain the most. However, staffing shortages may disrupt the trend.

Yahoo | December 15, 2022

How Much Upside is Left in HealthEquity (HQY)? Wall Street Analysts Think 30%

The mean of analysts' price targets for HealthEquity (HQY) points to a 29.9% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

Yahoo | December 15, 2022


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.5733 seconds.